XML 54 R40.htm IDEA: XBRL DOCUMENT v3.19.2
EMPLOYEE BENEFIT PLANS (Tables)
 12 Months Ended
May 31, 2019
Employee Benefits And Share Based Compensation [Abstract]  
Summary of Restricted Stock Based Award Activity

 

 

Restricted Stock-Based Awards Outstanding

 

(in millions, except fair value)

 

Number of

Shares

 

 

Weighted-Average

Grant Date Fair Value

 

Balance, May 31, 2016

 

 

52

 

 

$

39.29

 

Granted

 

 

42

 

 

$

39.40

 

Assumed

 

 

14

 

 

$

37.83

 

Vested and Issued

 

 

(18

)

 

$

40.39

 

Canceled

 

 

(7

)

 

$

39.73

 

Balance, May 31, 2017

 

 

83

 

 

$

39.18

 

Granted

 

 

44

 

 

$

47.42

 

Vested and Issued

 

 

(27

)

 

$

39.10

 

Canceled

 

 

(11

)

 

$

41.97

 

Balance, May 31, 2018

 

 

89

 

 

$

42.93

 

Granted

 

 

53

 

 

$

42.47

 

Vested and Issued

 

 

(31

)

 

$

41.85

 

Canceled

 

 

(12

)

 

$

42.97

 

Balance, May 31, 2019

 

 

99

 

 

$

43.01

 
Summary of Stock Option Activity

 

 

 

Options Outstanding

 

(in millions, except exercise price)

 

Shares Under

Stock Option

 

 

Weighted-Average

Exercise Price

 

Balance, May 31, 2016

 

 

375

 

 

$

29.66

 

Granted(1)

 

 

18

 

 

$

40.90

 

Assumed

 

 

2

 

 

$

13.06

 

Exercised

 

 

(77

)

 

$

26.65

 

Canceled

 

 

(6

)

 

$

36.28

 

Balance, May 31, 2017

 

 

312

 

 

$

29.02

 

Granted(2)

 

 

77

 

 

$

50.95

 

Exercised

 

 

(78

)

 

$

28.78

 

Canceled

 

 

(7

)

 

$

45.70

 

Balance, May 31, 2018

 

 

304

 

 

$

36.11

 

Granted

 

 

7

 

 

$

43.47

 

Exercised

 

 

(72

)

 

$

28.32

 

Canceled

 

 

(17

)

 

$

49.28

 

Balance, May 31, 2019

 

 

222

 

 

$

37.78

 

 

(1)

6.75 million SOs were granted in total during fiscal 2017 to our Chief Executive Officers and Chief Technology Officer and have contractual lives of five years versus the ten-year contractual lives for most of the other SOs granted.

(2)

Awards granted in fiscal 2018 included 66.5 million PSOs granted in total to our Chief Executive Officers, Chief Technology Officer, and former President, Product Development, the contractual terms of which are described in greater detail above.

 

 

 

Outstanding

Stock Options

(in millions)

 

 

 

 

Weighted-Average

Exercise Price

 

 

 

 

Weighted-Average

Remaining Contract Term

(in years)

 

 

 

 

Aggregate

Intrinsic Value(1)

(in millions)

 

Vested

 

 

146

 

 

 

 

$

32.13

 

 

 

 

 

3.32

 

 

 

 

$

2,698

 

Expected to vest(2)

 

 

42

 

 

 

 

$

46.95

 

 

 

 

 

6.47

 

 

 

 

 

181

 

Total

 

 

188

 

 

 

 

$

35.45

 

 

 

 

 

4.02

 

 

 

 

$

2,879

 

 

(1)

The aggregate intrinsic value was calculated based on the gross difference between our closing stock price on the last trading day of fiscal 2019 of $50.60 and the exercise prices for all “in-the-money” options outstanding, excluding tax effects.

(2)

The unrecognized compensation expense calculated under the fair value method for shares expected to vest (unvested shares net of expected forfeitures) as of May 31, 2019 was approximately $254 million and is expected to be recognized over a weighted-average period of 2.74 years. Approximately 34 million shares outstanding as of May 31, 2019 were not expected to vest.
Valuation of Stock Options

 

 

Year Ended May 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Expected life (in years)

 

 

4.6

 

 

 

4.7

 

 

 

4.8

 

Risk-free interest rate

 

2.7%

 

 

2.0%

 

 

1.0%

 

Volatility

 

24%

 

 

22%

 

 

23%

 

Dividend yield

 

1.7%

 

 

1.5%

 

 

1.5%

 

Weighted-average fair value per share

 

$

10.77

 

 

$

9.34

 

 

$

8.18

 
Stock-Based Compensation Expense

 

 

Year Ended May 31,

 

(in millions)

 

2019

 

 

2018

 

 

2017

 

Cloud services and license support

 

$

99

 

 

$

82

 

 

$

54

 

Hardware

 

 

10

 

 

 

10

 

 

 

11

 

Services

 

 

49

 

 

 

52

 

 

 

44

 

Sales and marketing

 

 

360

 

 

 

361

 

 

 

306

 

Research and development

 

 

963

 

 

 

921

 

 

 

770

 

General and administrative

 

 

172

 

 

 

180

 

 

 

130

 

Acquisition related and other

 

 

—

 

 

 

1

 

 

 

35

 

Total stock-based compensation

 

 

1,653

 

 

 

1,607

 

 

 

1,350

 

Estimated income tax benefit included in provision for income taxes

 

 

(358

)

 

 

(451

)

 

 

(423

)

Total stock-based compensation, net of estimated income tax benefit

 

$

1,295

 

 

$

1,156

 

 

$

927